Cardlytics Return on Equity

Cardlytics (CDLX) currently reports a ROE of 626.59%. That is above the Consumer Discretionary sector average of 14.05%. Use the charts on this page to explore Cardlytics's ROE history and peer comparisons.

Cardlytics's ROE of 626.59% is higher than the Consumer Discretionary sector average of 14.05%. That is roughly 4360.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Cardlytics's current 626.59% should be judged against Consumer Discretionary norms (sector average: 14.05%) and against CDLX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 626.59%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Discretionary average is 14.05%. From there, open related valuation or income-statement pages for Cardlytics, and consider following CDLX for alerts when major investors trade the stock.

Cardlytics is classified in the Consumer Discretionary sector. On ROE, it currently shows 626.59% versus a sector average near 14.05%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Discretionary are usually more informative than comparing CDLX with unrelated industries.